Canada Life
TXG icon

Canada Life’s 10x Genomics TXG Stock Holding History

Canada Life’s Portfolio TXG Stock Details TXG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$982K Buy
25,638
+2,138
+9% +$56K ﹤0.01% 1367
2026
Q1 		$500K Sell
23,500
-2,348
-9% -$46.9K ﹤0.01% 1501
2025
Q4 		$421K Buy
25,848
+483
+2% +$7.3K ﹤0.01% 1537
2025
Q3 		$287K Buy
25,365
+3,296
+15% +$43K ﹤0.01% 1667
2025
Q2 		$256K Buy
22,069
+13,831
+168% +$126K ﹤0.01% 1688
2025
Q1 		$72K Sell
8,238
-19,670
-70% -$248K ﹤0.01% 1827
2024
Q4 		$400K Sell
27,908
-3,038
-10% -$47.9K ﹤0.01% 1677
2024
Q3 		$700K Buy
30,946
+164
+0.5% +$3.39K ﹤0.01% 1609
2024
Q2 		$599K Buy
30,782
+2,060
+7% +$53.9K ﹤0.01% 1640
2024
Q1 		$1.08M Buy
28,722
+241
+0.8% +$10.6K ﹤0.01% 1489
2023
Q4 		$1.58M Buy
28,481
+1,548
+6% +$67.4K ﹤0.01% 1349
2023
Q3 		$1.11M Buy
26,933
+5,437
+25% +$283K ﹤0.01% 1447
2023
Q2 		$1.21M Buy
21,496
+2,568
+14% +$139K ﹤0.01% 1436
2023
Q1 		$1.06M Sell
18,928
-246
-1% -$11.5K ﹤0.01% 1484
2022
Q4 		$703K Buy
19,174
+6,817
+55% +$223K ﹤0.01% 1629
2022
Q3 		$351K Buy
12,357
+8,066
+188% +$307K ﹤0.01% 1756
2022
Q2 		$195K Sell
4,291
-58,343
-93% -$3.03M ﹤0.01% 1821
2022
Q1 		$5.04M Buy
62,634
+2,165
+4% +$189K 0.01% 758
2021
Q4 		$8.99M Buy
60,469
+18,667
+45% +$2.86M 0.02% 617
2021
Q3 		$6.13M Buy
41,802
+18,517
+80% +$3.18M 0.01% 674
2021
Q2 		$4.56M Buy
23,285
+3,994
+21% +$723K 0.01% 744
2021
Q1 		$3.47M Buy
19,291
+1,336
+7% +$231K 0.01% 827
2020
Q4 		$2.54M Buy
+17,955
New +$2.61M ﹤0.01% 1017

Other funds holding TXG

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
QCM
Quantinno Capital Management New York $83.3B AUM 37.97% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.75B AUM 33.73% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Canada Life's TXG Position: Q2 2026 in Review

Canada Life increased its 10x Genomics (TXG) stake by 9.1% in Q2 2026, buying an estimated $56K and bringing the position to 25,638 shares worth $982K. The position accounts for ﹤0.01% of the portfolio, ranked #1367.

Canada Life first reported a position in TXG in Q4 2020 and has held it in 23 quarters since. The position peaked at $8.99M in Q4 2021. 392 funds tracked by Wall St. Rank hold TXG as of Q2 2026.

  • Canada Life held 25,638 shares of 10x Genomics worth $982K as of Q2 2026.
  • Canada Life bought 2,138 10x Genomics shares in Q2 2026, an estimated $56K.
  • 10x Genomics made up ﹤0.01% of Canada Life's portfolio in Q2 2026, its #1367 holding.
  • Canada Life first reported a position in 10x Genomics in Q4 2020 and has held it in 23 quarters since.
  • Canada Life's 10x Genomics position peaked at $8.99M in Q4 2021.
  • 392 funds tracked by Wall St. Rank held 10x Genomics as of Q2 2026.

Based on Canada Life's 13F filing for Q2 2026, filed 13 Aug 2026.